Weak Induction of Interferon Expression by SARS-CoV-2 Supports Clinical Trials of Interferon Lambda to Treat Early COVID-19.
Identifieur interne : 000005 ( PubMed/Curation ); précédent : 000004; suivant : 000006Weak Induction of Interferon Expression by SARS-CoV-2 Supports Clinical Trials of Interferon Lambda to Treat Early COVID-19.
Auteurs : Thomas R. O'Brien [États-Unis] ; David L. Thomas [États-Unis] ; Sarah S. Jackson [États-Unis] ; Ludmila Prokunina-Olsson [États-Unis] ; Raymond P. Donnelly [États-Unis] ; Rune Hartmann [Danemark]Source :
- Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [ 1537-6591 ] ; 2020.
DOI: 10.1093/cid/ciaa453
PubMed: 32301957
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000005
Links to Exploration step
pubmed:32301957Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Weak Induction of Interferon Expression by SARS-CoV-2 Supports Clinical Trials of Interferon Lambda to Treat Early COVID-19.</title><author><name sortKey="O Brien, Thomas R" sort="O Brien, Thomas R" uniqKey="O Brien T" first="Thomas R" last="O'Brien">Thomas R. O'Brien</name><affiliation wicri:level="1"><nlm:affiliation>Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD</wicri:regionArea></affiliation></author><author><name sortKey="Thomas, David L" sort="Thomas, David L" uniqKey="Thomas D" first="David L" last="Thomas">David L. Thomas</name><affiliation wicri:level="1"><nlm:affiliation>Johns Hopkins University, School of Medicine, Baltimore, MD, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Johns Hopkins University, School of Medicine, Baltimore, MD</wicri:regionArea></affiliation></author><author><name sortKey="Jackson, Sarah S" sort="Jackson, Sarah S" uniqKey="Jackson S" first="Sarah S" last="Jackson">Sarah S. Jackson</name><affiliation wicri:level="1"><nlm:affiliation>Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD</wicri:regionArea></affiliation></author><author><name sortKey="Prokunina Olsson, Ludmila" sort="Prokunina Olsson, Ludmila" uniqKey="Prokunina Olsson L" first="Ludmila" last="Prokunina-Olsson">Ludmila Prokunina-Olsson</name><affiliation wicri:level="1"><nlm:affiliation>Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD</wicri:regionArea></affiliation></author><author><name sortKey="Donnelly, Raymond P" sort="Donnelly, Raymond P" uniqKey="Donnelly R" first="Raymond P" last="Donnelly">Raymond P. Donnelly</name><affiliation wicri:level="1"><nlm:affiliation>Division of Biotechnology Research and Review II, Center for Drug Evaluation & Research, Food and Drug Administration, Silver Spring, MD, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Biotechnology Research and Review II, Center for Drug Evaluation & Research, Food and Drug Administration, Silver Spring, MD</wicri:regionArea></affiliation></author><author><name sortKey="Hartmann, Rune" sort="Hartmann, Rune" uniqKey="Hartmann R" first="Rune" last="Hartmann">Rune Hartmann</name><affiliation wicri:level="1"><nlm:affiliation>Dept of Molecular Biology and Genetics, University of Aarhus, Gustav Wieds vej 10, DK, Aarhus C., Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>Dept of Molecular Biology and Genetics, University of Aarhus, Gustav Wieds vej 10, DK, Aarhus C.</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32301957</idno><idno type="pmid">32301957</idno><idno type="doi">10.1093/cid/ciaa453</idno><idno type="wicri:Area/PubMed/Corpus">000005</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000005</idno><idno type="wicri:Area/PubMed/Curation">000005</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000005</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Weak Induction of Interferon Expression by SARS-CoV-2 Supports Clinical Trials of Interferon Lambda to Treat Early COVID-19.</title><author><name sortKey="O Brien, Thomas R" sort="O Brien, Thomas R" uniqKey="O Brien T" first="Thomas R" last="O'Brien">Thomas R. O'Brien</name><affiliation wicri:level="1"><nlm:affiliation>Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD</wicri:regionArea></affiliation></author><author><name sortKey="Thomas, David L" sort="Thomas, David L" uniqKey="Thomas D" first="David L" last="Thomas">David L. Thomas</name><affiliation wicri:level="1"><nlm:affiliation>Johns Hopkins University, School of Medicine, Baltimore, MD, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Johns Hopkins University, School of Medicine, Baltimore, MD</wicri:regionArea></affiliation></author><author><name sortKey="Jackson, Sarah S" sort="Jackson, Sarah S" uniqKey="Jackson S" first="Sarah S" last="Jackson">Sarah S. Jackson</name><affiliation wicri:level="1"><nlm:affiliation>Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD</wicri:regionArea></affiliation></author><author><name sortKey="Prokunina Olsson, Ludmila" sort="Prokunina Olsson, Ludmila" uniqKey="Prokunina Olsson L" first="Ludmila" last="Prokunina-Olsson">Ludmila Prokunina-Olsson</name><affiliation wicri:level="1"><nlm:affiliation>Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD</wicri:regionArea></affiliation></author><author><name sortKey="Donnelly, Raymond P" sort="Donnelly, Raymond P" uniqKey="Donnelly R" first="Raymond P" last="Donnelly">Raymond P. Donnelly</name><affiliation wicri:level="1"><nlm:affiliation>Division of Biotechnology Research and Review II, Center for Drug Evaluation & Research, Food and Drug Administration, Silver Spring, MD, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Biotechnology Research and Review II, Center for Drug Evaluation & Research, Food and Drug Administration, Silver Spring, MD</wicri:regionArea></affiliation></author><author><name sortKey="Hartmann, Rune" sort="Hartmann, Rune" uniqKey="Hartmann R" first="Rune" last="Hartmann">Rune Hartmann</name><affiliation wicri:level="1"><nlm:affiliation>Dept of Molecular Biology and Genetics, University of Aarhus, Gustav Wieds vej 10, DK, Aarhus C., Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>Dept of Molecular Biology and Genetics, University of Aarhus, Gustav Wieds vej 10, DK, Aarhus C.</wicri:regionArea></affiliation></author></analytic><series><title level="j">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</title><idno type="eISSN">1537-6591</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32301957</PMID><DateRevised><Year>2020</Year><Month>04</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1537-6591</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year><Month>Apr</Month><Day>17</Day></PubDate></JournalIssue><Title>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</Title><ISOAbbreviation>Clin. Infect. Dis.</ISOAbbreviation></Journal><ArticleTitle>Weak Induction of Interferon Expression by SARS-CoV-2 Supports Clinical Trials of Interferon Lambda to Treat Early COVID-19.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">ciaa453</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/cid/ciaa453</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>O'Brien</LastName><ForeName>Thomas R</ForeName><Initials>TR</Initials><AffiliationInfo><Affiliation>Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>David L</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>Johns Hopkins University, School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jackson</LastName><ForeName>Sarah S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prokunina-Olsson</LastName><ForeName>Ludmila</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donnelly</LastName><ForeName>Raymond P</ForeName><Initials>RP</Initials><AffiliationInfo><Affiliation>Division of Biotechnology Research and Review II, Center for Drug Evaluation & Research, Food and Drug Administration, Silver Spring, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hartmann</LastName><ForeName>Rune</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Dept of Molecular Biology and Genetics, University of Aarhus, Gustav Wieds vej 10, DK, Aarhus C., Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Infect Dis</MedlineTA><NlmUniqueID>9203213</NlmUniqueID><ISSNLinking>1058-4838</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">MERS-CoV</Keyword><Keyword MajorTopicYN="N">Middle East respiratory syndrome</Keyword><Keyword MajorTopicYN="N">SARS-CoV</Keyword><Keyword MajorTopicYN="N">innate immunity</Keyword><Keyword MajorTopicYN="N">public health</Keyword><Keyword MajorTopicYN="N">severe acute respiratory syndrome</Keyword><Keyword MajorTopicYN="N">virology</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>04</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32301957</ArticleId><ArticleId IdType="pii">5821272</ArticleId><ArticleId IdType="doi">10.1093/cid/ciaa453</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000005 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000005 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:32301957
|texte= Weak Induction of Interferon Expression by SARS-CoV-2 Supports Clinical Trials of Interferon Lambda to Treat Early COVID-19.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:32301957" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a MersV1
| This area was generated with Dilib version V0.6.33. |  |